Top Markets
#1 Akedo Akedo +59.31%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +50.07%
#4 Velvet Velvet +43.76%
#5 Black Phoenix Black Phoenix +34.55%
#6 τemplar τemplar +26.67%
#7 Not in Employment, Education, or Training Not in Employment, Education, or Training +18.66%
#8 Bitway Bitway +18.26%
#9 Perle Perle +16.48%
#10 Cap Cap +16.47%
Coin of the day
Akedo Akedo
設定
言語
日本
通貨
USD
テーマ
Entourage Health Corp. Entourage Health Corp.

Entourage Health Corp.

ENTG
株式のランク #38299
Headquartered in Toronto, Canada, Entourage Health Corp. specializes in the... Headquartered in Toronto, Canada, Entourage Health Corp. specializes in the cultivation and distribution of various cannabis products for both the medical and recreational markets across Canada. Their comprehensive product line features cannabis plants, dried flower, oils, topical applications, concentrated extracts, and edible forms. These offerings are available under a portfolio of brands, such as Color Cannabis, Saturday Cannabis, Starseed Medicinals, and Mary's Medicinals. The company adopted its current name, Entourage Health Corp., in July 2021, having previously been known as WeedMD Inc.
株価
$0.00350576
最終同期: 2025-04-08
時価総額
$1.08M
変化（1日）
-0.16%
変化（1年）
0.00%
国
CA
取引 Entourage Health Corp. (ENTG)

カテゴリー

Healthcare
Entourage Health Corp.（ENTG）のP/S比率
2026 時点のP/S比率 TTM: 0
Entourage Health Corp. の最新の財務報告および株価によると、現在のP/S比率（TTM）は 0 です。2026 年末時点でのP/S比率は 0 でした。
Entourage Health Corp. の P/S 比率の履歴（2026 ～ 2026）
各年末時点のP/S比率
年 P/S比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/S比率
企業 P/S比率 P/S比率の差 国
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
- -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
- -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
- -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
- -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
8.17 -
IN